Association of SGLT2 inhibitors use with a lower risk of biliary diseases in patients with type 2 diabetes mellitus: a retrospective cohort study
SGLT2i use was associated with a lower BD risk in T2DM patients, particularly with long-term treatment and among high-risk subgroups. Improved biliary biomarkers paralleled this reduction, suggesting a potential link that warrants further study.
Authors
- Dongming Su
- Kaini Zhang
- Xinyu Chen (ORCID: https://orcid.org/0000-0002-4111-4720)
- Ying Liu (ORCID: https://orcid.org/0000-0002-1312-0146)
- Wei Lü (ORCID: https://orcid.org/0000-0002-3009-1025)
- Xiaoli Chen
- Kaiyue Hu
- Ming Gao (ORCID: https://orcid.org/0000-0002-1152-5983)
- Tingxi Zhu
- Bei Zhong
- S H Tang
- Ying Zhang
- Xiubin Liang
- Zheng Gong
Institutions
- China Pharmaceutical University (CN)
- Sir Run Run Shaw Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2026-02-02
- DOI
- https://doi.org/10.1080/07853890.2026.2619263
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 30.73